Qube Research & Technologies Ltd
Position in AMLX — Amylyx Pharmaceuticals, Inc.
CIK 1729829
LONDON, X0
Position in AMLX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$12,237,746
+$2,476,666 QoQ
Shares Held
681,389
-3.0% QoQ
Ownership
0.612%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#35
of 207 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMLX Over Time
Shares Held
Position Value (USD)
Derivatives in AMLX
reported options exposure · as of Mar 31, 2024CallValue
$0
CallShares
0
PutValue
$44,304
PutShares
15,600
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Qube Research & Technologies Ltd holds $592,833,307 across 20 Drug Manufacturers - Specialty & Generic names. AMLX ranks #11 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
2,279,333 | $163,792,869 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
233,639 | $126,592,619 | |
| 3 | VTRS |
Viatris Inc
|
6,180,223 | $98,141,941 | |
| 4 | SUPN |
Supernus Pharmaceuticals, Inc.
|
922,166 | $42,889,940 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,207,432 | $35,385,134 | |
| 6 | XERS |
Xeris Biopharma Holdings, Inc.
|
2,893,749 | $22,918,492 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
304,080 | $19,445,916 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
192,945 | $15,971,987 |
All Filings in AMLX
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,237,746 | 681,389 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $9,761,080 | 702,236 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,987,505 | 412,873 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,270,970 | 167,106 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,807,746 | 438,026 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,337,834 | 942,891 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,950,539 | 780,566 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $595,816 | 183,894 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,499,340 | 789,127 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $44,304 | 15,600 | Put | Sole | 2024-05-14 | |
| 2024-03-31 | $2,681,138 | 944,063 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $7,103,857 | 482,599 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,979,220 | 162,710 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,678,562 | 124,180 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $930,811 | 31,725 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||